deltatrials
Completed NA NCT02398279

L-arginine add-on Therapy in Patients With Schizophrenia

L-Arginine add-on Treatment for Schizophrenia: A Randomized, Double Blind, Placebo Controlled, Cross Over Study

Sponsor: Hacettepe University

Conditions Schizoaffective Disorder Schizophrenia
Interventions L-Arginine Placebo
Updated 6 times since 2017 Last updated: Mar 19, 2015 Started: Jun 30, 2011 Primary completion: Dec 31, 2012 Completion: Apr 30, 2013

A NA clinical study on Schizoaffective Disorder and Schizophrenia, this trial is completed. The trial is conducted by Hacettepe University and has accumulated 6 data snapshots since 2011. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hacettepe University
Data source: Hacettepe University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ankara, Turkey (Türkiye)